Bulk Drugs

Enal Drugs plans expansion programme at Wangapally

Enal Drugs is planning an expansion programme of its plant in Wangapally in Yadagirigutta in Nalagonda district of Telangana. The project involves expanding manufacturing capacity of active pharmaceutical ingredients from 966 tpa to 1800 tpa. The project cost is estimated at Rs. 400 million. After expansion, the plant will produce Lansoprazole, Rabeprazole Sodium, Zalepon, Omeprazole and other anti ulcerative drug intermediates.
Read More

Telangana to unveil new Pharma policy

Telangana government is ready to unveil a draft new policy on Pharma and Bulk Drug Sector. The state government has acquired 11,000 acres of land at Mucherla at the outskirts of Hyderabad . (roughly 70 kms away ) They are in the process of preparing a detailed project report (DPR) in coordination with the pharma industry and the pollution control board so that every ingredient required for the industry and environment safety is incorporated. With the ?Make in India policy? of the government, the industry is expecting sops like tax breaks, weighted tax deduction at 150 per cent for R&D expenditure and availability of affordable land for the industry. Already, Hyderabad has a strong base for bulk drug industries in India contributing one third of country?s bulk drug production. Taking t
Read More


  • No Image
    Corey Organics Ltd

    Corey Organics Private Ltd was incorporated in 1994, is engaged in the manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (API). The company has

  • No Image
    Cornileus Pharmaceuticals Pvt Ltd

    Cornileus Pharmaceuticals owns a state-of-the-art infrastructural set-up. With a registered office in Hyderabad, India, the manufacturing site is located in the Special Economic

  • No Image
    CPR Laboratories Pvt Ltd

    CPR Laboratories Pvt Ltd was formed as a One Person Company in March 2016 with the objective of manufacturing bulk drugs of different therapeutic categories. The registered offi